What Are Nuvation Bio Inc.'s Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 |
|---|---|---|---|
| Revenue | $63 million | $8 million | $0 |
| Operating income | -$213 million | -$593 million | -$100 million |
| Operating margin | -338.7% | -7527.3% | n/a |
| Net income | -$205 million | -$568 million | -$76 million |
| Net margin | -325.3% | -7213.8% | n/a |
| Operating cash flow | -$173 million | -$130 million | -$68 million |
| Capital expenditures | $8 million | $0 | Not reported |
| Free cash flow | -$181 million | -$130 million | Not reported |
Operating margin widened by 7188.6 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was -$181 million against net income of -$205 million; cash generation covered reported earnings.
What Does Nuvation Bio Inc.'s Balance Sheet Show?
| Cash and cash equivalents | $164 million |
|---|---|
| Long-term debt | $47 million |
| Total assets | $595 million |
| Total liabilities | $289 million |
| Shareholders' equity | $306 million |
| Current ratio | 7.0x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Nuvation Bio Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001193125-26-085584 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 12, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Nuvation Bio Inc.'s revenue in fiscal 2025?
Nuvation Bio Inc. reported revenue of $63 million for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Nuvation Bio Inc.'s operating margin?
Nuvation Bio Inc.'s operating margin was -338.7% in fiscal 2025: operating income of -$213 million on revenue of $63 million.
How much free cash flow did Nuvation Bio Inc. generate?
Operating cash flow of -$173 million less capital expenditures of $8 million gives free cash flow of -$181 million for fiscal 2025.